PROFUSA, INC. Payable Common Stock Redeemed
PROFUSA, INC. (PFSA) had Payable Common Stock Redeemed of $1.57 million as of 2024-01-31, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Financial Services › Investment Company
us-gaap:PayableCommonStockRedeemed · last filed 2025-08-14
- 2024-01-31: Payable Common Stock Redeemed $1.57M.
- 2023-12-31: Payable Common Stock Redeemed $1.57M.
- 2023-03-22: Payable Common Stock Redeemed $184.85M.
| Period end | Payable Common Stock Redeemed |
|---|---|
| 2024-01-31 | $1.57M 10-Q · filed 2025-08-14 |
| 2023-12-31 | $1.57M 10-K · filed 2024-02-26 |
| 2023-03-22 | $184.85M 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |